"Wilmington GI specializes in colon cancer screening and diagnosis and treatment of digestive disorders, providing unparalleled service and quality in gastrointestinal care. Telemedicine appointments are available. Our clinical staff includes seven gastroenterologists, board certified in both gastroenterology and hepatology, and a specialized team of physician assistants. D. Spencer Carney, MD Kunal S. Dalal, MD Robert D. J. Henihan, MD William W. King, MD Steven D. Klein, MD Mariam Sauer, MD Justin Miller, MD Our state-of-the art, AAAHC accredited, ASGE recognized and Medicare Certified facility provides colonoscopy and a full range of endoscopic services, typically at a lower cost compared to other surgical centers or hospital settings."

During the past decade, Wilmington Gastroenterology Associates conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilmington Gastroenterology Associates" #1 sponsor was "Exact Sciences Corporation" with 3 trials, followed by "Bausch Health Americas, Inc." with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "Colotech A/S" with 1 trials sponsored and "Janssen Scientific Affairs, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilmington Gastroenterology Associates" #1 collaborator was "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wilmington Gastroenterology Associates" are "Ulcerative Colitis" (4 trials), "Colorectal Cancer" (2 trials), "Inflammatory Bowel Disease" (2 trials), "Adenomatous Polyps" (1 trials) and "Colo-rectal Cancer" (1 trials). Many other conditions were trialed in "Wilmington Gastroenterology Associates" in a lesser frequency.

Most popular intervention types in "Wilmington Gastroenterology Associates" are "Drug" (5 trials), "Procedure" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Colonoscopy" (2 trials), "Mesalamine" (2 trials), "Placebo" (2 trials), "0.5 mg calcitriol (1a -25-dihydroxycholecalciferol)" (1 trials) and "75 mg acetylsalicylic acid (ASA) + 1250 mg calcium carbonate (CaCO3)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wilmington Gastroenterology Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Wilmington Gastroenterology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Wilmington Gastroenterology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wilmington Gastroenterology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".